The provided information summarizes a federal contract indefinite delivery vehicle (IDV) awarded by the U.S. Department of Veterans Affairs (VA) to Amgen USA Inc., a division of the leading biotechnology company Amgen Inc. The contract, a Federal Supply Schedule (FSS) under the GSA Pharmaceuticals and Drugs (FSS-61-IB) schedule, has a ceiling value of $3.37 billion and allows Amgen to supply pharmaceuticals, drugs, and hematology-related products to various federal agencies.
Specifically, the IDV has been used to award a $65,478.18 firm fixed-price delivery order for the pharmaceutical product TAVNEOS (AVACOPAN) to the VA's Veterans Integrated Service Network 20. This order has an ultimate completion date of September 30, 2024. Amgen USA Inc. also holds a separate $58.97 million single-award IDV from the VA National Acquisition Center for supplying calcitonin gene-related peptide agents to the VA, Bureau of Prisons, and Indian Health Service. These IDVs demonstrate Amgen's role in providing critical medical supplies to support federal healthcare initiatives.
Generated 3/13/25, 10:06 AM